• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.70 1,418.30(%)
  • Reliance Industries
    1,303.90 1,152.30(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Saregama India
    613.80 305.65(%)
  • Bajaj Finance
    1,054.00 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shelter Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 73691.0
  • ISIN : INE013V01011
49.00 2 (4.79%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    48.50

  • Today’s High

    49.00

  • Open

    48.50

  • Perv Close

    46.76

  • 52W Low

    23.00

  • 52W High

    55.88

Key Indicators

  • P/E(TTM)

    9.14

  • Mar.Cap (₹Cr.)

    82.50

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.16

  • Debt-Equity Ratio

    4.79

  • AGM Date

    04-Nov-2026

  • EPS

    5.36

  • P/E Ratio

    9.14

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    82.50

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.84

  • BV (₹)

    43.20

  • Sales( ₹ in Cr.)

    73.13

  • NP (in Cr.)

    9.03

  • NP Var(%)

    25.0

  • Div%

    0.0

  • CPS (₹)

    5.60

  • EPS (₹)

    5.40

  • Traded Value (₹ in Lakhs)

    82.50

  • 52 Week High

    55.88

  • 52 Week Low

    23.00

  • Price BSE

    49.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    82.50

  • P/C Ratio

    8.70

  • P/E Ratio

    9.10

  • Price Vs.BV

    5.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 73.13 50.66 40.02 36.15 30.06 22.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 73.13 50.66 40.02 36.15 30.06 22.48
Other Income 0.02 0.01 0.00 0.00 0.00 0.01
Stock Adjustments 0.04 0.12 -0.07 0.06 1.00 -0.03
Total Income 73.19 50.79 39.95 36.21 31.06 22.46
EXPENDITURE :            
Raw Materials 55.61 37.15 28.85 26.31 26.85 21.11
Power and Fuel Cost 0.11 0.08 0.07 0.06 0.05 0.05
Employee Cost 1.13 1.22 0.63 0.45 0.35 0.33
Other Manufacturing Expenses 0.36 0.37 0.40 0.30 0.27 0.29
Selling and Administration Expenses 2.68 1.32 0.77 0.52 0.45 0.49
Miscellaneous Expenses 0.54 0.56 0.46 1.40 0.03 0.01
Employee Benefit Expenses 1.13 1.22 0.63 0.45 0.35 0.33
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 60.43 40.71 31.16 29.04 28.01 22.26
Operating Profit 12.75 10.08 8.79 7.18 3.05 0.20
Interest 0.12 0.13 0.26 0.03 0.08 0.02
Gross Profit 12.63 9.95 8.53 7.15 2.97 0.18
Depreciation 0.41 0.27 0.25 0.16 0.17 0.12
Profit Before Tax 12.22 9.68 8.28 6.99 2.80 0.06
Current Tax 3.17 2.44 2.12 1.76 0.75 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.03 0.00 -0.04 0.02 0.00 0.00
Reported Net Profit 9.03 7.24 6.20 5.21 2.06 0.04
Extraordinary Items 0.00 0.00 0.00 -0.72 0.00 0.00
Adjusted Net Profit 9.03 7.24 6.20 5.93 2.06 0.04
Adjustment below Net Profit -0.43 -0.33 -0.96 0.54 -0.37 -0.30
P & L Balance brought forward 18.01 11.10 5.86 3.38 1.69 1.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 26.61 18.01 11.10 9.13 3.38 1.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.43 6.26 5.36 6.72 42.54 0.85
Earnings Per Share(Adj)-Unit Curr 5.43 6.26 5.36 - - -
Book Value 43.18 36.14 30.17 17.57 162.45 127.48
Book Value(Adj)-Unit Curr 43.18 36.14 30.17 - - -

Shareholding Pattern

  • Promoter Group

    46.11%

  • Public Share Holding

    53.89%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,977,000 46.11 7,977,000 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,977,000 46.11 7,977,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 537,792 3.11 537,792 23
Clearing Members 27,000 0.16 27,000 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 189,000 1.09 189,000 34
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 237,000 1.37 237,000 36
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,689,000 27.10 4,689,000 48
Individuals holding nominal share capital up to Rs. 1 lakh 3,531,000 20.41 3,531,000 862
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 9,000 0.05 9,000 1
Sub Total 9,324,792 53.89 9,324,792 1,009
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,301,792 100.00 17,301,792 1,015

Company Background

Shelter Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Shelter Pharma Ltd
  • BSE Code : 73691.0
  • ISIN : INE013V01011

  • Incorporation Year

    2007

  • Registered Office

    Shelter Nagar
    Near S T Bus Stand, Himmatnagar,
    Gujarat-383001

  • Telephone

    91-0277-2296038

  • FAX

  • Chairman

    MUSTAQIM NISARAHMED SABUGAR

  • Managing Director

    MUSTAQIM NISARAHMED SABUGAR

  • Company Secretary

    Aarefa Kutub Kapasi

  • Auditor

    Alvi & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Shelter Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shelter Pharma 49.00 73.15 73.13 9.14 20.68
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77